Investor mix
6 investors on record; lead investors include BioGenerator, Axia Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Other / undisclosed | 1 | 17% |
Developing stroma-targeted oncolytic immunotherapy to unleash the immune response against cancer
6 investors on record; lead investors include BioGenerator, Axia Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Other / undisclosed | 1 | 17% |